After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Castle Biosciences Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. The current market capitalization of Castle Biosciences Inc is $696.49M. A total of 0.52 million shares were traded on the day, compared to an average of 514.82K shares.
In the most recent transaction, Oelschlager Kristen M sold 12,677 shares of CSTL for 22.02 per share on Aug 27 ’25. After the transaction, the Chief Operating Officer now owns 141,116 company shares. In a previous transaction on Aug 27 ’25, Oelschlager Kristen M sold 18,007 shares at 21.69 per share. CSTL shares that Chief Operating Officer owns now total 153,793.
Among the insiders who bought shares, Kristen M. Oelschlager acquired of 18,007 shares on Aug 27 ’25 at a per-share price of $21.35. In another insider transaction, Kristen M. Oelschlager bought 25,355 shares at $21.35 per share on Aug 27 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CSTL has a high of $35.84 and a low of $14.59.
As of this writing, CSTL has an earnings estimate of -$0.52 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$0.71. The company reported an EPS of $0.08 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CSTL’s latest balance sheet shows that the firm has $329.63M in Cash & Short Term Investments as of fiscal 2021. There were $8.20M in debt and $24.89M in liabilities at the time. Its Book Value Per Share was $15.71, while its Total Shareholder’s Equity was $411.74M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CSTL is Buy with a score of 4.80.
